Heterophilic antibody blocker for BEK-2217, BEK-2221, BEK-22 - 500 µg
BL-004-500 contains a proprietary mixture of proteins and buffer reagents designed to reduce heterophilic interactions in ELISA assays utilizing sheep immunoreagents.
Following ELISA assays in the Biosensis RapidTM ELISA range have been validated to achieve accurate results using BL-004-500:
BEK-2217/2240, Human proBDNF; Application: Serum, Citrate-Plasma
BEK-2221, Human NT3; Application: Plasma (Citrate and EDTA)
BEK-2237, Human proBDNF; Application: Serum, EDTA-Plasma
One vial of BL-004-500 contains 500 μg IgG which is sufficient as sample diluent additive for one 96-well plate.
Other ELISA assays that use sheep assay antibodies may also benefit from addition of blocker BL-004-500, but require optimization of working concentration and assay validation for accurate results.
Following ELISA assays in the Biosensis RapidTM ELISA range have been validated to achieve accurate results using BL-004-500:
BEK-2217/2240, Human proBDNF; Application: Serum, Citrate-Plasma
BEK-2221, Human NT3; Application: Plasma (Citrate and EDTA)
BEK-2237, Human proBDNF; Application: Serum, EDTA-Plasma
One vial of BL-004-500 contains 500 μg IgG which is sufficient as sample diluent additive for one 96-well plate.
Other ELISA assays that use sheep assay antibodies may also benefit from addition of blocker BL-004-500, but require optimization of working concentration and assay validation for accurate results.
Supplier Catalog Number |
BL-004-500 |
|---|---|
Shipping conditions |
Room temperature |
Storage Temperature |
+4°C |
Supplier name |
Biosensis |
From
€70.00
Total
€70.00
In stock
- SKU
- P00744972::500 µg
No surprise after checkout. All fees included
Your satisfaction first: door delivery with guaranteed replacement
Dedicated Scientific Support to select & use
Recently Viewed Products
of